Suppr超能文献

糖尿病性黄斑水肿和玻璃体视网膜牵引的玻璃体切割术结果。

Vitrectomy outcomes in eyes with diabetic macular edema and vitreomacular traction.

机构信息

Wills Eye Institute.

出版信息

Ophthalmology. 2010 Jun;117(6):1087-1093.e3. doi: 10.1016/j.ophtha.2009.10.040. Epub 2010 Mar 17.

Abstract

PURPOSE

To evaluate vitrectomy for diabetic macular edema (DME) in eyes with at least moderate vision loss and vitreomacular traction.

DESIGN

Prospective cohort study.

PARTICIPANTS

The primary cohort included 87 eyes with DME and vitreomacular traction based on investigator's evaluation, visual acuity 20/63-20/400, optical coherence tomography (OCT) central subfield >300 microns and no concomitant cataract extraction at the time of vitrectomy.

METHODS

Surgery was performed according to the investigator's usual routine. Follow-up visits were performed after 3 months, 6 months (primary end point), and 1 year.

MAIN OUTCOME MEASURES

Visual acuity, OCT retinal thickening, and operative complications.

RESULTS

At baseline, median visual acuity in the 87 eyes was 20/100 and median OCT thickness was 491 microns. During vitrectomy, additional procedures included epiretinal membrane peeling in 61%, internal limiting membrane peeling in 54%, panretinal photocoagulation in 40%, and injection of corticosteroids at the close of the procedure in 64%. At 6 months, median OCT central subfield thickness decreased by 160 microns, with 43% having central subfield thickness <250 microns and 68% having at least a 50% reduction in thickening. Visual acuity improved by > or =10 letters in 38% (95% confidence interval, 28%-49%) and deteriorated by > or =10 letters in 22% (95% confidence interval, 13%-31%). Postoperative complications through 6 months included vitreous hemorrhage (5 eyes), elevated intraocular pressure requiring treatment (7 eyes), retinal detachment (3 eyes), and endophthalmitis (1 eye). Few changes in results were noted between 6 months and 1 year.

CONCLUSIONS

After vitrectomy performed for DME and vitreomacular traction, retinal thickening was reduced in most eyes. Between 28% and 49% of eyes with characteristics similar to those included in this study are likely to have improvement of visual acuity, whereas between 13% and 31% are likely to have worsening. The operative complication rate is low and similar to what has been reported for this procedure. These data provide estimates of surgical outcomes and serve as a reference for future studies that might consider vitrectomy for DME in eyes with at least moderate vision loss and vitreomacular traction.

摘要

目的

评估玻璃体切割术治疗伴有至少中度视力丧失和玻璃体黄斑牵引的糖尿病性黄斑水肿(DME)。

设计

前瞻性队列研究。

参与者

主要队列包括 87 只眼睛,这些眼睛基于研究者的评估患有 DME 和玻璃体黄斑牵引,视力 20/63-20/400,光学相干断层扫描(OCT)中央凹 300 微米以上,并且在玻璃体切割术时没有同时进行白内障摘除。

方法

根据研究者的常规程序进行手术。术后 3 个月、6 个月(主要终点)和 1 年进行随访。

主要观察指标

视力、OCT 视网膜增厚和手术并发症。

结果

在基线时,87 只眼中的中位数视力为 20/100,中位数 OCT 厚度为 491 微米。在玻璃体切割术中,附加程序包括 61%的内界膜剥除、54%的内界膜剥除、40%的全视网膜光凝以及 64%的皮质类固醇注射。在 6 个月时,中位数 OCT 中央凹厚度减少了 160 微米,43%的中央凹厚度<250 微米,68%的厚度减少了 50%以上。38%(95%置信区间,28%-49%)的视力提高了>或=10 个字母,22%(95%置信区间,13%-31%)的视力恶化了>或=10 个字母。术后 6 个月的并发症包括玻璃体积血(5 只眼)、需要治疗的眼压升高(7 只眼)、视网膜脱离(3 只眼)和眼内炎(1 只眼)。在 6 个月和 1 年之间,结果的变化很小。

结论

对于 DME 和玻璃体黄斑牵引进行玻璃体切割术后,大多数眼睛的视网膜增厚减少。类似于本研究纳入标准的眼睛中,28%至 49%的眼睛可能会提高视力,而 13%至 31%的眼睛可能会恶化。手术并发症发生率较低,与该手术的报告相似。这些数据提供了手术结果的估计,并为未来可能考虑在至少中度视力丧失和玻璃体黄斑牵引的情况下进行 DME 玻璃体切割术的研究提供了参考。

相似文献

1
Vitrectomy outcomes in eyes with diabetic macular edema and vitreomacular traction.
Ophthalmology. 2010 Jun;117(6):1087-1093.e3. doi: 10.1016/j.ophtha.2009.10.040. Epub 2010 Mar 17.
2
Early postoperative retinal thickness changes and complications after vitrectomy for diabetic macular edema.
Am J Ophthalmol. 2003 Jan;135(1):14-9. doi: 10.1016/s0002-9394(02)01819-6.
3
Pars plana vitrectomy with internal limiting membrane peeling for diabetic macular edema.
Retina. 2008 Mar;28(3):410-9. doi: 10.1097/IAE.0b013e31816102f2.
4
Vitrectomy for Diabetic Macular Edema: Optical Coherence Tomography Criteria and Pathology of the Vitreomacular Interface.
Am J Ophthalmol. 2019 Apr;200:34-46. doi: 10.1016/j.ajo.2018.12.004. Epub 2018 Dec 14.
8
Optical coherence tomography for evaluating diabetic macular edema before and after vitrectomy.
Am J Ophthalmol. 2003 Feb;135(2):169-77. doi: 10.1016/s0002-9394(02)01837-8.
9
10
Pars plana vitrectomy with internal limiting membranectomy for refractory diabetic macular edema without a taut posterior hyaloid.
Graefes Arch Clin Exp Ophthalmol. 2005 Jan;243(1):20-5. doi: 10.1007/s00417-004-0958-z. Epub 2004 Jul 31.

引用本文的文献

1
Modulation of Oxidative Stress in Diabetic Retinopathy: Therapeutic Role of Natural Polyphenols.
Antioxidants (Basel). 2025 Jul 17;14(7):875. doi: 10.3390/antiox14070875.
5
Vitrectomy for diabetic retinopathy: A review of indications, techniques, outcomes, and complications.
Taiwan J Ophthalmol. 2024 Jan 31;14(4):519-530. doi: 10.4103/tjo.TJO-D-23-00108. eCollection 2024 Oct-Dec.
6
Ultrastructural imaging biomarkers in diabetic macular edema: A major review.
Indian J Ophthalmol. 2025 Jan 1;73(Suppl 1):S7-S23. doi: 10.4103/IJO.IJO_878_24. Epub 2024 Dec 24.

本文引用的文献

1
Long-term follow-up of vitrectomy for diffuse nontractional diabetic macular edema.
Retina. 2009 Apr;29(4):464-72. doi: 10.1097/IAE.0b013e31819c632f.
3
A randomized trial comparing intravitreal triamcinolone acetonide and focal/grid photocoagulation for diabetic macular edema.
Ophthalmology. 2008 Sep;115(9):1447-9, 1449.e1-10. doi: 10.1016/j.ophtha.2008.06.015. Epub 2008 Jul 26.
6
Evaluating adjunctive surgical procedures during vitrectomy for diabetic macular edema.
Retina. 2006 Feb;26(2):143-8. doi: 10.1097/00006982-200602000-00003.
8
Vitrectomy with removal of the internal limiting membrane in chronic diabetic macular oedema.
Graefes Arch Clin Exp Ophthalmol. 2004 Aug;242(8):630-7. doi: 10.1007/s00417-003-0849-8. Epub 2004 Jun 22.
9
Visual outcome of patients with macular edema after pars plana vitrectomy and indocyanine green-assisted peeling of the internal limiting membrane.
Graefes Arch Clin Exp Ophthalmol. 2004 Apr;242(4):273-8. doi: 10.1007/s00417-003-0731-8. Epub 2004 Mar 23.
10
Vitrectomy with internal limiting membrane removal for clinically significant macular oedema.
Graefes Arch Clin Exp Ophthalmol. 2004 May;242(5):402-8. doi: 10.1007/s00417-004-0876-0. Epub 2004 Feb 18.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验